Epstein Nancy E, Abulnick Marc A
Clinical Professor of Neurosurgery, School of Medicine, State University of NY at Stony Brook, and Editor-in-Chief Surgical Neurology International NY and c/o Dr. Marc Agulnick 1122 Franklin Avenue Suite 106, Garden City, NY 11530, United States.
Department of Orthopedics, Assistant Clinical Professor of Orthopedics, NYU Langone Hospital, Long Island, Garden City, New York, 1122 Franklin Avenue Suite 106 Garden City, NY 11530, United States.
Surg Neurol Int. 2023 Aug 25;14:303. doi: 10.25259/SNI_648_2023. eCollection 2023.
Anterior transthoracic, posterolateral (i.e., costotransversectomy/lateral extracavitary), and transpedicular approaches are now utilized to address anterior, anterolateral, or lateral thoracic disk herniations (TDH). Notably, laminectomy has not been a viable option for treating TDH for decades due to the much lower rate of acceptable outcomes (i.e., 57% for decompressive laminectomy vs. over 80% for the posterolateral, lateral, and transthoracic procedures), and a higher risk of neurological morbidity/paralysis.
Patients with TDH averaged 48-56.3 years of age, and presented with pain (76%), myelopathy (61%-99%), radiculopathy (30%-33%), and/or sphincter loss (16.7%-24%). Those with anterior/anterolateral TDH (30-74%) were usually myelopathic while those with more lateral disease (50-70%) exhibited radiculopathy. Magnetic resonance (MR) studies best defined soft-tissue/disk/cord pathology, CAT scan (CT)/Myelo-CT studies identified attendant discal calcification (i.e. fully calcified 38.9% -65% vs. partial calcification 27.8%), while both exams documented giant TDH filling > 30 to 40% of the canal (i.e., in 43% to 77% of cases).
Surgical options for anterior/anterolateral TDH largely included transthoracic or posterolateral approaches (i.e. costotransversectomy, lateral extracavitary procedures) with the occasional use of transfacet/transpedicular procedures mostly applied to lateral disks. Notably, patients undergoing transthoracic, lateral extracavitary/costotransversectomy/ transpedicular approaches may additionally warrant fusions. Good/excellent outcomes were quoted in from 45.5% to 87% of different series, with early postoperative adverse events reported in from 14 to 14.6% of patients.
Anterior/anterolateral TDH are largely addressed with transthoracic or posterolateral procedures (i.e. costotransversectomy/extracavitary), with a subset also utilizing transfacet/transpedicular approaches typically adopted for lateral TDH. Laminectomy is essentially no longer considered a viable option for treating TDH.
目前采用经胸前路、后外侧(即肋骨横突切除术/外侧胸腔外入路)和经椎弓根入路来处理胸椎椎间盘突出症(TDH)的前路、前外侧或外侧病变。值得注意的是,几十年来,椎板切除术一直不是治疗TDH的可行选择,因为其可接受的治疗效果比率低得多(即减压性椎板切除术为57%,而后外侧、外侧和经胸手术超过80%),且神经功能障碍/瘫痪风险更高。
TDH患者平均年龄为48 - 56.3岁,表现为疼痛(76%)、脊髓病(61% - 99%)、神经根病(30% - 33%)和/或括约肌功能丧失(16.7% - 24%)。那些患有前路/前外侧TDH(30% - 74%)的患者通常有脊髓病,而那些患有更外侧病变(50% - 70%)的患者表现为神经根病。磁共振(MR)研究最能明确软组织/椎间盘/脊髓病变,计算机断层扫描(CT)/脊髓CT研究可识别伴随的椎间盘钙化情况(即完全钙化38.9% - 65%,部分钙化27.8%),而两种检查都记录了巨大TDH占据椎管30%至40%以上的情况(即43%至77%的病例)。
前路/前外侧TDH的手术选择主要包括经胸或后外侧入路(即肋骨横突切除术、外侧胸腔外手术),偶尔会使用经关节突/经椎弓根手术,主要用于外侧椎间盘。值得注意的是,接受经胸、外侧胸腔外/肋骨横突切除术/经椎弓根入路的患者可能还需要进行融合手术。不同系列报道的良好/优秀治疗效果比例为45.5%至87%,14%至14.6%的患者术后早期出现不良事件。
前路/前外侧TDH主要通过经胸或后外侧手术(即肋骨横突切除术/胸腔外入路)来处理,一部分患者还会采用通常用于外侧TDH的经关节突/经椎弓根入路。椎板切除术基本上不再被认为是治疗TDH的可行选择。